Experiences and perspectives of cancer stakeholders regarding COVID-19 vaccination.

Bartley, N; Havard, P; Butow, P; Shaw, J; COVID-19 Cancer Stakeholder Authorship Group,

Experiences and perspectives of cancer stakeholders regarding COVID-19 vaccination.

Bartley, N

Havard, P Butow, P Shaw, J COVID-19 Cancer Stakeholder Authorship Group,

Permalink

Publisher:: WILEY
Publication Type:: Journal Article
Citation:: Asia Pac J Clin Oncol, 2022
Issue Date:: 2022-07-18

Open Access

Copyright Clearance Process

Recently Added
In Progress
Open Access

This item is open access.

Adobe PDF

Download Published versionAdobe PDF (160.69 kB)

View on publisher's site

View statistics

Full metadata record

Field	Value	Language
dc.contributor.author	Bartley, N https://orcid.org/0000-0001-9052-1616
dc.contributor.author	Havard, P
dc.contributor.author	Butow, P
dc.contributor.author	Shaw, J
dc.contributor.author	COVID-19 Cancer Stakeholder Authorship Group,
dc.date.accessioned	2022-12-02T02:02:19Z
dc.date.available	2022-06-13
dc.date.available	2022-12-02T02:02:19Z
dc.date.issued	2022-07-18
dc.identifier.citation	Asia Pac J Clin Oncol, 2022
dc.identifier.issn	1743-7555
dc.identifier.issn	1743-7563
dc.identifier.uri	http://hdl.handle.net/10453/164046
dc.description.abstract	AIM: The risk of dying from COVID-19 is higher for those who are older, immune-compromised, or chronically ill. Vaccines are an effective strategy in reducing mortality and morbidity from COVID-19. However, for COVID-19 vaccination programs to reach full potential, vaccines must be taken up by those at greatest risk, such as cancer patients. Understanding the perspectives of all stakeholders involved in cancer patient COVID-19 vaccine uptake will be critical to ensuring appropriate support, and information is provided to facilitate vaccination. The aim of this research was to explore the longitudinal views of cancer stakeholders regarding COVID-19 vaccination. METHODS: Semistructured interviews were conducted with cancer patients (n = 23), family members (n = 10), cancer health professionals (n = 19), and representatives of cancer nongovernment organizations (n = 7) across Australia 6 and 12 months postrecruitment. Transcripts were thematically analyzed, using an inductive approach. RESULTS: All stakeholder groups expressed mostly positive attitudes toward COVID-19 vaccination, with the following key themes identified: (1) high motivation-vaccination perceived as offering health protection and hope; (2) hesitancy-concern about vaccine hesitancy among the general population, with a minority hesitant themselves; (3) confusion and frustration-regarding the vaccine rollout and patient eligibility; (4) uncertainty-about vaccination in the context of cancer; (5) access to vaccination; and (6) desire for expert individualized advice-on vaccine interaction with cancer treatments. CONCLUSION: These findings highlight the COVID-19 vaccine concerns and information needs of cancer stakeholders. Policymakers need to provide clear tailored information regarding vaccine eligibility, accessibility, benefits, and risks to facilitate vaccine uptake.
dc.format	Print-Electronic
dc.language	eng
dc.publisher	WILEY
dc.relation.ispartof	Asia Pac J Clin Oncol
dc.relation.isbasedon	10.1111/ajco.13808
dc.rights	info:eu-repo/semantics/openAccess
dc.subject	1112 Oncology and Carcinogenesis
dc.subject.classification	Oncology & Carcinogenesis
dc.title	Experiences and perspectives of cancer stakeholders regarding COVID-19 vaccination.
dc.type	Journal Article
utslib.location.activity	Australia
utslib.for	1112 Oncology and Carcinogenesis
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Health
utslib.copyright.status	open_access	*
dc.date.updated	2022-12-02T02:02:18Z
pubs.publication-status	Published online

Abstract:

AIM: The risk of dying from COVID-19 is higher for those who are older, immune-compromised, or chronically ill. Vaccines are an effective strategy in reducing mortality and morbidity from COVID-19. However, for COVID-19 vaccination programs to reach full potential, vaccines must be taken up by those at greatest risk, such as cancer patients. Understanding the perspectives of all stakeholders involved in cancer patient COVID-19 vaccine uptake will be critical to ensuring appropriate support, and information is provided to facilitate vaccination. The aim of this research was to explore the longitudinal views of cancer stakeholders regarding COVID-19 vaccination. METHODS: Semistructured interviews were conducted with cancer patients (n = 23), family members (n = 10), cancer health professionals (n = 19), and representatives of cancer nongovernment organizations (n = 7) across Australia 6 and 12 months postrecruitment. Transcripts were thematically analyzed, using an inductive approach. RESULTS: All stakeholder groups expressed mostly positive attitudes toward COVID-19 vaccination, with the following key themes identified: (1) high motivation-vaccination perceived as offering health protection and hope; (2) hesitancy-concern about vaccine hesitancy among the general population, with a minority hesitant themselves; (3) confusion and frustration-regarding the vaccine rollout and patient eligibility; (4) uncertainty-about vaccination in the context of cancer; (5) access to vaccination; and (6) desire for expert individualized advice-on vaccine interaction with cancer treatments. CONCLUSION: These findings highlight the COVID-19 vaccine concerns and information needs of cancer stakeholders. Policymakers need to provide clear tailored information regarding vaccine eligibility, accessibility, benefits, and risks to facilitate vaccine uptake.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/164046